Consolidated Statement Of Cash Flows

Human Metabolome Technologies, Inc. - Filing #7308027

Concept 2023-07-01 to
2024-06-30
As at
2024-06-30
As at
2023-06-30
2022-07-01 to
2023-06-30
As at
2022-06-30
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
236,702,000 JPY
306,176,000 JPY
Interest and dividends received
14,000 JPY
14,000 JPY
Interest paid
-2,095,000 JPY
-2,265,000 JPY
Net cash provided by (used in) operating activities
236,795,000 JPY
284,962,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-32,479,000 JPY
-98,786,000 JPY
Net cash provided by (used in) investing activities
-32,441,000 JPY
-116,755,000 JPY
Cash flows from financing activities
Purchase of treasury shares
JPY
-23,000 JPY
Dividends paid
-58,696,000 JPY
JPY
Net cash provided by (used in) financing activities
-73,153,000 JPY
-13,754,000 JPY
Effect of exchange rate change on cash and cash equivalents
516,000 JPY
-2,407,000 JPY
Net increase (decrease) in cash and cash equivalents
131,717,000 JPY
152,045,000 JPY
Cash and cash equivalents
1,788,506,000 JPY
1,656,789,000 JPY
1,504,744,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.